We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+13.46%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.15B
AUM Growth
+$28.4M
Cap. Flow
-$577M
Cap. Flow %
-26.84%
Top 10 Hldgs %
29.86%
Holding
143
New
30
Increased
17
Reduced
35
Closed
30

Top Buys

Rank Stock Value
1
RNA
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
+$75.8M
2
THOR
THORATEC CORPORATION
THOR
+$31.1M
3
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$30.7M
4
VTRS icon
Viatris
VTRS
+$27.4M
5
TRAW icon
Traws Pharma
TRAW
+$24.3M

Top Sells

Rank Stock Value
1
OPTR
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
+$43.8M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$42.7M
3
NKTR icon
Nektar Therapeutics
NKTR
+$34M
4
STJ
St Jude Medical
STJ
+$24M
5
SGNT
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
+$23.8M

Sector Composition

Rank Sector Weight
1 Healthcare 52.2%
2 Technology 1.35%
3 Financials 1.05%
4 Consumer Discretionary 0%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRGE
126
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
– –
-688,510
Closed -$2.48M
AFAM
127
DELISTED
Almost Family Inc
AFAM
– –
-13,200
Closed -$252K
2 3 4 5
6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q3 2013 Portfolio in Review

As of Q3 2013, Deerfield Management held 143 positions worth $2.15B, up 1.3% from $2.12B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Deerfield Management withdrew a net $577M in Q3 2013, closing 30 positions and reducing 35 holdings. Its most notable exit was OPTIMER PHARMACEUTICALS, INC. COM STK, an estimated $43.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 51% a quarter earlier, followed by Technology and Financials.

Against the trend, Deerfield Management opened a new position in PROSENSA HLDGS N V ORD SHS (NLD) worth $21.3M.

  • Deerfield Management's largest Q3 2013 buy was PROSENSA HLDGS N V ORD SHS (NLD): 3,224,524 shares worth $21.3M.
  • Deerfield Management added most to Spectrum Pharmaceuticals Inc in Q3 2013, an estimated $24.3M increase.
  • Deerfield Management's biggest Q3 2013 reduction was AUXILIUM PHARAMCEUTICALS INC, cutting an estimated $42.7M.
  • Deerfield Management fully exited OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013, selling an estimated $43.8M.
  • Deerfield Management's ten largest holdings make up 30% of its $2.15B portfolio in Q3 2013.
  • Deerfield Management opened 30 new positions and closed 30 in Q3 2013.
  • Deerfield Management's portfolio value rose 1.3% quarter-over-quarter to $2.15B.

Based on Deerfield Management's 13F filing for Q3 2013, filed 14 Nov 2013.